Caricamento...
P13.07 Phase II study of systemic high-dose methotrexate and intrathecal liposomal cytarabine for treatment of breast cancer with leptomeningeal metastases
BACKGROUND: Metastatic breast cancer frequently leads to brain metastases and, less commonly, leptomeningeal carcinomatosis (LC). Once cerebro-spinal fluid (CSF) involvement occurs the prognosis is poor with median survival between 3–7 months. There are limited treatment options available, but none...
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782744/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.251 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|